Demonstration of mast-cell chemotactic activity in nasal lavage fluid: Characterization of one chemotaxin as c-kit ligand, stem cell factor

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue 9, 1998, Pages 874-879

  Nilsson, G ^a   Hjertson, M ^a   Andersson, M ^c   Greiff, L ^c   Svensson, C ^c   Nilsson, K ^a   Siegbahn, A ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allergy; Chemotaxis; Mast cell; Migration; Mucosa; Stem cell factor

Indexed keywords

BUDESONIDE; LEVOCABASTINE; STEM CELL FACTOR;

ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MAST CELL; NEUTROPHIL CHEMOTAXIS; NOSE SECRETION; PRIORITY JOURNAL; PROTEIN SECRETION; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL;

EID: 0031712729     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb03994.x     Document Type: Article

References (42)

1. Nilsson G, Schwartz LB. Mast cell heterogeneity: structure and mediators. In: Busse WW, Holgate ST, editors. Asthma and rhinitis. Boston, MA: Blackwell Science, 1995:195-208.
2. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993;147:697-704.
3. Enerbäck L, Pipkorn U, Granerus G. Intraepithelial migration of nasal mucosal mast cells in hay fever. Int Arch Allergy Immunol 1986;80:44-50.
4. Chanez P, Lacoste JY, Guillot B, et al. Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung. Am Rev Respir Dis 1993;147:1497-1502.
5. Wasserman SI. The mast cell and synovial inflammation. Or, what's a nice cell like you doing in a joint like this? Arthritis Rheum 1987;27:841-4.
6. Viegas M, Gomez E, Brooks J, Davies RJ. Changes in mast cell numbers in and out of the pollen season. Int Arch Allergy Appl Immunol 1987;82:275-6.
7. Okuda M, Ohtsuka H, Kawabori S. Basophil leukocytes and mast cells in the nose. Eur J Respir Dis 1983;64 Suppl 128:7-14.
8. Kawabori S, Okuda M, Unno T, Nakamura A. Dynamics of mast cell degranulation in human allergic nasal epithelium after provocation with allergen. Clin Allergy 1985; 15:509-15.
9. Borres MP, Irander K, Björkstén B. Metachromatic cells in nasal mucosa after allergen challenge. Allergy 1990;45: 98-103.
10. Fokkens WJ, Godthelp T, Holm AF, et al. Dynamics of mast cells in the nasal mucosa of patients with allergic rhinitis and non-allergic controls: a biopsy study. Clin Exp Allergy 1992;22:701-10.
11. Juliusson S, Pipkorn U, Karlsson G, Enerbäck L. Mast cells and eosinophils in the allergic mucosal response to allergen challenge: changes in distribution and signs of activation in relation to symptoms. J Allergy Clin Immunol 1992;90: 898-909.
12. Kawabori S, Kanai N, Tosho T. Proliferative activity of mast cells in allergic nasal mucosa. Clin Exp Allergy 1995;25: 173-8.
13. Valent P, Spanblöchl E, Sperr WR, et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/-kit-ligand in long-term culture. Blood 1992;80:2237-45.
14. Irani AA, Nilsson G, Miettinen U, et al. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 1992; 80:3009-21.
15. Butterfield JH, Weiler D, Dewald G, Gleich GJ. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 1988;12:345-55.
16. Nilsson G, Blom T, Kusche GM, et al. Phenotypic characterization of the human mast cell line HMC-1. Scand J Immunol 1994;39:489-98.
17. Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB, Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci U S A 1986; 83:4464-8.
18. Andersson M, Svensson C, Greiff L, Blychert L, Alkner U, Persson CGA. Effects of topical levocabastine and budesonide on nasal responsiveness during a Swedish birch pollen season. Eur Respir J 1995;8 Suppl 19:138.
19. Greiff L, Pipkorn U, Alkner U, Persson CGA. The nasal pool device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions. Clin Exp Allergy 1990;20:253-9.
20. Nilsson G, Butterfield JH, Nilsson K, Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 1994;153:3717-23.
21. Siegbahn A, Hammacher A, Westermark B, Heldin CH. Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblast, monocytes, and granulocytes. J Clin Invest 1990;85:916-20.
22. Sulakvelidze I, Marshall JS, Dolovich J. Mast cells in rhinitis. In: Busse WW, Holgate ST, editors. Asthma and rhinitis. Boston, MA: Blackwell Scientific, 1994:231-41.
23. Otsuka H, Denburg J, Dolovich J, et al. Heterogeneity of metachromatic cells in human nose: significance of mucosal mast cells. J Allergy Clin Immunol 1985;76: 695-702.
24. Kawabori S, Okuda M, Unno T. Mast cells in allergic nasal epithelium and lamina propria before and after provocation. Clin Allergy 1983;13:181-9.
25. Pipkorn U, Karlsson G, Enerbäck L. Nasal mucosal response to repeated challenges with pollen allergen. Am Rev Respir Dis 1989;140:729-36.
26. Viegas M, Gomez E, Brooks J, Gatland D, Davies RJ. Effect of the pollen season on nasal mast cells. BMJ 1987; 294:414.
27. Meininger CJ, Yano H, Rottapel R, Bernstein A, Zsebo KM, Zetter BR. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 1992;79:958-63.
28. Mattoli S, Ackerman V, Vittori E, Marini M. Mast cell chemotactic activity of RANTES. Biochem Biophys Res Commun 1995;209:316-21.
29. Nocka K, Buck J, Levi E, Besmer P. Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. EMBO J 1990;9:3287-94.
30. Aye MT, Hashemi S, Leclair B, et al. Expression of stem cell factor and c-kit mRNA in cultured endothelial cells, monocytes and cloned human bone marrow stromal cells (CFU-RF). Exp Hematol 1992;20:523-7.
31. Heinrich MC, Dooley DC, Freed AC, et al. Constitutive expression of steel factor gene by human stromal cells. Blood 1993;82:771-83.
32. Longley BJ, Morganroth GS, Tyrrell L, et al. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 1993;328:1302-7.
33. Wen LP, Fahrni JA, Matsui S, Rosen GD. Airway epithelial cells produce stem cell factor. Biochim Biophys Acta 1996; 1314:183-6.
34. Kim YK, Nakagawa N, Nakano K, Sulakvelidze I, Dolovich J, Denhurg J. Stem cell factor in nasal polyposis and allergic rhinitis: increased expression by structural cells is suppressed by in vivo topical corticosteroids. J Allergy Clin Immunol 1997;100:389-99.
35. Pipkorn U, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med 1987;316:1506-10.
36. Okuda M, Sakaguchi K, Otsuka H. Intranasal beclomethasone: mode of action in nasal allergy. Ann Allergy 1983;50:116-20.
37. Gomez E, Clague JE, Gatland D, Davies RJ. Effect of topical corticosteroids on seasonally induced increases in nasal mast cells. BMJ 1988;296:1572-3.
38. Pipkorn U, Enerbäck L. Nasal mucosal mast cells and histamine in hay fever. Effect of topical glucocorticoid treatment. Int Arch Allergy Appl Immunol 1987;84:123-8.
39. Lozewicz S, Wang J, Duddle J, et al. Topical glucocorticoids inhibit activation by allergen in the upper respiratory tract. J Allergy Clin Immunol 1992;89:951-7.
40. Juliusson S, Holmberg K, Karlsson G, Enerbäck L, Pipkorn U. Mast cells and mediators in the nasal mucosa after allergen challenge. Effects of four weeks' treatment with topical glucocorticoid. Clin Exp Allergy 1993;23:591-9.
41. Orgel HA, Meltzer EO, Bierman CW, et al. Intranasal fluocortin butyl in patients with perennial rhinitis: a 12-month efficacy and safety study including nasal biopsy. J Allergy Clin Immunol 1991;88:257-64.
42. Togias AG, Naclerio RM, Warner J, et al. Demonstration of inhibition of mediator release from human mast cells by azatadine base. In vivo and in vitro evaluation. JAMA 1986;255:225-9.